MedPath
HSA Approval

NOSPAN TABLET 30 mg

SIN10341P

NOSPAN TABLET 30 mg

NOSPAN TABLET 30 mg

November 4, 1998

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R05DA09

dextromethorphan

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y S P INDUSTRIES (M) SDN BHD

Active Ingredients

DEXTROMETHORPHAN HBr

30.00 mg

Dextromethorphan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NOSPAN TABLET 30 mg - HSA Approval | MedPath